Precursor Condition
Cervical Squamous Intraepithelial Neoplasia
CI-CAN-00002175CINExplore in graph →
Precursor3 active trials
- NCIt
- C7346
Loading cancer entity…
Precursor Condition
CI-CAN-00002175CINExplore in graph →
Clinical trials
19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06979180 | A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV. | recruiting | N/A | 60 | Papillex Inc.INDUSTRY | 1 | Jul 8, 2026 | clinicaltrials |
| NCT04712851 | Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia | recruiting | Phase 2 | 25 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Mar 10, 2026 | clinicaltrials |
Showing 1–2 of 2 studies
Data updated 22 days agoSource updated Jul 8, 2026source: clinicaltrials